APA aipamena

Innes, A. J., Cook, L. B., Marks, S., Bataillard, E., Crossette‐Thambiah, C., Sivasubramaniam, G., . . . Milojkovic, D. (2020). Ruxolitinib for tocilizumab‐refractory severe COVID‐19 infection. Br J Haematol.

Chicago Style aipamena

Innes, Andrew J., Lucy B. Cook, Sasha Marks, Edward Bataillard, Christina Crossette‐Thambiah, Gayathiri Sivasubramaniam, Jane Apperley, and Dragana Milojkovic. "Ruxolitinib for Tocilizumab‐refractory Severe COVID‐19 Infection." Br J Haematol 2020.

MLA aipamena

Innes, Andrew J., et al. "Ruxolitinib for Tocilizumab‐refractory Severe COVID‐19 Infection." Br J Haematol 2020.